Gilead Sciences Declares First Quarterly Cash Dividend

Go back to Gilead Sciences Declares First Quarterly Cash Dividend

Gilead Sciences (GILD) 'Crushed' the Quarter, Piper Jaffray Says; Remains Top Large-Cap Biotech Pick

May 1, 2015 7:10 AM EDT

Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating and lifted his price target on Gilead Sciences (NASDAQ: GILD) to $120.00 (from $116.00) after the company "crushed" the quarter and raised its outlook.

Schimmer commented, "GILD hosted the 1Q earnings call after the... More

Gilead Sciences (GILD) Bullish Stance Reiterated at BMO Capital Amid 'Strong' Q1

May 1, 2015 7:00 AM EDT

BMO Capital analyst Jim Birchenough reiterated an Outperform rating and $159 price target on Gilead Sciences (NASDAQ: GILD) following "strong" Q1 results after the close with room to expand in HCV.

Birchenough commented, "We are maintaining our Outperform rating on the shares of GILD... More

Gilead Sciences (GILD) Declares $0.43 Quarterly Dividend; 1.7% Yield

April 30, 2015 5:21 PM EDT

Gilead Sciences (NASDAQ: GILD) declared a quarterly dividend of $0.43 per share, or $1.72 annualized.

The dividend will be payable on June 29, 2015, to stockholders of record on June 16, 2015, with an ex-dividend date of June 12, 2015.

The annual yield on the dividend is 1.7... More